References
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;19;3:CD004454.
- Brownfoot FC, Crowther CA, Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2008;8;4:CD004454.
- Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2007;18;3:CD003935.
- Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB. DART study investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 2006;117:75-83. https://doi.org/10.1542/peds.2004-2843
- Anderson PJ, Doyle LW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Periinatol 2006;30:227-32. https://doi.org/10.1053/j.semperi.2006.05.010
- O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG 3rd, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999;104:15-21. https://doi.org/10.1542/peds.104.1.15
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. https://doi.org/10.1164/ajrccm.163.7.2011060
- Gattinoni L, Pesenti A. The concept of "baby lung". Intensive Care Med 2005;31:776-84. https://doi.org/10.1007/s00134-005-2627-z
- Mishra R, Golombek SG, Ramirez-Tolentino SR, Das S, La Gamma EF. Low-birth-weight neonates exhibit a physiological set-point to regulate CO2: an untapped potential to minimize volutrauma-as-sociated lung injury. Am J Perinato 2003;20:453-63. https://doi.org/10.1055/s-2003-45388
- Goodman G, Perkin RM, Anas NG. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988;112:67-72. https://doi.org/10.1016/S0022-3476(88)80125-2
- Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007;120:1260-9. https://doi.org/10.1542/peds.2007-0971
- Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. New England Journal of Medicine 1998;338:1112-8. https://doi.org/10.1056/NEJM199804163381604
- Wilson-Costello D, Michele C, Walsh MC, Langer JC, Guillet R, Laptook AR, et al. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics 2009;123:e430-7. https://doi.org/10.1542/peds.2008-1928
- Gross SJ, Anbar RD, Mettelman BB. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics 2005;115:681-7. https://doi.org/10.1542/peds.2004-0956
- Onland W, Offringa M, De Jaegere AP, van Kaam AH. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopullmonary dysplasia: a systematic review of placebo-controlled trials. Pediatrics 2009;123:367-77. https://doi.org/10.1542/peds.2008-0016
- Watterberg KL, Shaffer ML, Mishefske MJ, Leach CL, Mammel MC, Couser RJ, et al. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics 2007;120:40-8. https://doi.org/10.1542/peds.2006-3158
- Jobe AH. Postnatal corticosteroids for bronchopulmonary dysplasia. Clin Perinatol 2009;36:177-88. https://doi.org/10.1016/j.clp.2008.09.016
- Ng PC, Lam CW, Lee CH, Chan IH, Wong SP, Fok TF. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants. Neonatology 2008;94:170-5. https://doi.org/10.1159/000143396
- Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-3. https://doi.org/10.1203/00006450-199912000-00001
- Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 1999;103:759-65. https://doi.org/10.1542/peds.103.4.759
- Choi CW, Kim BI, Koh YY, Choi JH, Choi JY. Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants. Pediatr Int 2005;47:72-9. https://doi.org/10.1111/j.1442-200x.2004.01996.x
- Bland RD. Neonatal chronic lung disease in the post-surfactant era. BioI Neonate 2005;88:181-91. https://doi.org/10.1159/000087581
- Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-7. https://doi.org/10.1016/S0046-8177(98)90280-5
- Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003;8:29-38. https://doi.org/10.1016/S1084-2756(02)00190-2
- Haroon Parupia MF, Dhanireddy R. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants. J Perinatol 2001;21:242-7. https://doi.org/10.1038/sj.jp.7200531